Denali Therapeutics Funding & Investors
Denali Therapeutics Inc. operates as a biotechnology company. The Company discovers and develops medicines for neurodegenerative diseases. Denali Therapeutics serves patients in the State of California.
denalitherapeutics.comTotal Amount Raised: $133,500,000
Denali Therapeutics Funding Rounds
Series D
$70,000,000
Series D Investors
Casdin CapitalCormorant Asset ManagementPerceptive AdvisorsRedmile GroupVenrockWellington ManagementTekla Capital ManagementDeerfield ManagementSeries C
$20,000,000
Series C Investors
Pfizer Venture InvestmentsThird Rock VenturesCanaan PartnersRoche Venture FundSeries B
$11,000,000
Series B Investors
Canaan PartnersThird Rock VenturesSeries B
$30,000,000
Series B Investors
Third Rock VenturesRoche Venture FundConvertible Note
$2,500,000
Convertible Note Investors
Mike Panesis
Funding info provided by Diffbot.